¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"CAR"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
4
ÄÚµå
¿µ¹®
ÇѱÛ
T53.0
Carbon tetrachloride
»ç¿°Èź¼Ò
Y54.2
Carbonic-anhydrase inhibitors
ź»ê ¾ÈÈ÷µå¶óÁ¦ ¾ïÁ¦Á¦
T50.2
Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
ź»êÅ»¼öÈ¿¼Ò ¾ïÁ¦Á¦, º¥Á¶Å¸À̾ƴÙÀ̾ÆÀÚÀÌµå ¹× ±âŸ ÀÌ´¢Á¦
E34.0
Carcinoid syndrome
Ä«¸£½Ã³ëÀ̵å ÁõÈıº
D05
Carcinoma in situ of breast
À¯¹æÀÇ »óÇdz» ¾ÏÁ¾
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½